Differences in Spatial Memory Impairment in Mice after Oral D-Galactose Administration and Intraperitoneal Injection
DOI:
https://doi.org/10.3889/oamjms.2020.4149Keywords:
Dementia, D-galactose, Intraperitoneal, OralAbstract
BACKGROUND: The aging process can increase the incidence of dementia, such as spatial memory impairment to remember space, recognize shapes and distances. Research on dementia in mice was carried out by administering d-galactose through intraperitoneal injection, while oral d-galactose administration had not received enough attention.
AIM: This study aims to prove the differences in the occurrence of spatial memory impairment in rats induced by d-galactose through two different routes, oral and intraperitoneal injection.
METHODS: This study is an experimental study using a post- test control group design. The sample criteria were 20 male Wistar rats aged 12–14 weeks, weighing 200–300 g divided into two groups which are the oral and intraperitoneal injection. Spatial memory assessment based on spontaneous alternation using the Y-maze test was carried out at the end of week 8.
RESULTS: In this study, the average spatial memory score after d-galactose administration in the injection group (51.572±4.388) was lower compared to the oral group (66.058±1.551). The Shapiro–Wilk normality test shows that the data are normally distributed with p > 0.05. Independent t-test showed a significant difference in the incidence of spatial memory disorders between the injection and oral groups with p = 0.010 (p < 0.05).
CONCLUSION: The conclusion of this study is that d-galactose administration by oral route or intraperitoneal injection causes a decrease in spatial memory in mice. Spatial memory in the injection group was lower than in the oral group. This might be related to the decrease in synaptophysin in the hippocampus of mice due to d-galactose administration by intraperitoneal injection.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Bishop NA, Lu T, Yankner BA. Neural mechanisms of ageing and cognitive decline. Nature. 2010;464(7288):529-35. https:// doi.org/10.1038/nature08983 PMid:20336135
Dogru EJ, Gumusbas U, Kara F. Individual variation in the spatial reference and working memory assesed under allothetic and idiothetic orientation cues in rat. Acta Neurobiol Exp (Wars). 2003;63(1):17-23. PMid:12784928
Sharma S, Rakoczy S, Brown-Borg H. Assessment of spatial memory in mice. Life Sci. 2010;87(17-18):521-36. https://doi. org/10.1016/j.lfs.2010.09.004 PMid:20837032
Wright RL, Conrad CD. Chronic stress leave novelty-seeking behaviour intact while imparing spatial recognition memory in the Y-maze. Stress. 2005;8:151-4. https://doi. org/10.1080/10253890500156663 PMid:16019606
Rehman SU, Shah SA, Ali T, Chung JI, Kim MO. Anthocyanins reversed D-galactose-induced oxidative stress and neuroinflammation mediated cognitive impairment in adult rats. Mol Neurobiol. 2017;54(1):255-71. https://doi.org/10.1007/ s12035-015-9604-5 PMid:26738855
Du Z, Hu Y, Yang Y, Sun Y, Zhang S, Zhou T, et al. NADPH oxidase-dependent oxidative stress and mitochondrial damage in hippocampus of D-galactose-induced aging rats. J Huazhong Univ Sci Technol Med Sci. 2012;32(4):466-72. https://doi. org/10.1007/s11596-012-0081-z PMid:22886955
Chogtu B, Arivazhahan A, Kunder SK, Tilak A, Sori R, Tripathy A. Evaluation of acute and chronic effects of D-galactose on memory and learning in Wistar rats. Clin Psychopharmacol Neurosci. 2018;16(2):153-60. https://doi.org/10.9758/cpn.2018.16.2.153 PMid:29739128
Budni J, Pacheco R, da Silva S, Garcez ML, Mina F, Bellettini-Santos T, et al. Oral administration of D-galactose induces cognitive impairments and oxidative damage in rats. Behav Brain Res. 2016;302:35-43. https://doi.org/10.1016/j. bbr.2015.12.041 PMid:26748256
Cardoso A, Magano SS, Marrana F, Andrade JP. D-galactose high-dose administration failed to induce accelerated aging changes in neurogenesis, anxiety, and spatial memory on young male Wistar rats. Rejuvenation Res. 2015;18(6):497-507. https://doi.org/10.1089/rej.2015.1684 PMid:25936362
Salkovic-Petrisic M. Oral galactose provides a different approach to incretin-based therapy of Alzheimer’s disease. J Neurol Neuromed. 2018;3(4):101-7. https://doi.org/10.29245/2 572.942x/2018/4.1204
Downloads
Published
How to Cite
License
Copyright (c) 2020 Ketut Widyastuti, AAA P Laksmidewi, I Made Oka Adnyana, DPG Purwa Samatra (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
